GC Biopharma Builds AI System for Hemophilic Arthropathy

GC Biopharma has been selected for Korea’s Ministry of Health and Welfare’s Advanced Bio Convergence Talent Development Project to create the world’s first AI-based clinical decision support system designed specifically to forecast hemophilic arthropathy. Currently, standardized models capable of quantitatively assessing the long-term risk of joint deterioration remain limited in practice. This initiative addresses that […]

The post GC Biopharma Builds AI System for Hemophilic Arthropathy first appeared on HHM Global | B2B Online Platform & Magazine.